| Dr Gerald Joseph Fleischli, MD | |
|
1232 University Of Oregon, University Of Oregon Health Center, Eugene, OR 97403-1232 | |
| (541) 346-0565 | |
| Not Available |
| Full Name | Dr Gerald Joseph Fleischli |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1232 University Of Oregon, Eugene, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033230206 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 17518 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gerald Joseph Fleischli, MD 34977 Meadow Ln, Creswell, OR 97426-9469 Ph: (541) 895-2143 | Dr Gerald Joseph Fleischli, MD 1232 University Of Oregon, University Of Oregon Health Center, Eugene, OR 97403-1232 Ph: (541) 346-0565 |
News Archive
More than two-thirds of all type-2 diabetes patients do not achieve good control of their disease with the first-line medication metformin combined with second-line insulin shots.
BioVentrix, developer of the PliCath HF™ System for use in Epicardial Catheter-based Ventricular Reconstruction (ECVR), today announced achievement of its First-in-Man milestone, performed on a 52-year-old male heart failure patient in Krakow, Poland. The PliCath HF System is designed to treat heart failure (HF) by reducing the enlarged Left Ventricle (LV) through an anchoring system that is delivered across the cardiac chambers with the use of a catheter.
Resverlogix Corp. today announced that new data on RVX-208 was presented at the ERA-EDTA Congress in London, England in a poster entitled: "Effects of RVX-208, a First-in-Class Epigenetic BET-Inhibitor, on Key Renal Parameters in Subjects with a History of CVD, and Chronic Kidney Disease (CKD); a Post-hoc Analysis of Patients from the ASSERT, SUSTAIN and ASSURE Clinical Trials."
Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM Institute (I-STEM/ Inserm UEVE U861/AFM), published in the Lancet on 21 November 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells.
A new study published in Investigative Ophthalmology & Visual Science found that between 40 to 50 percent of older adults with visually impairing eye disease limit their activities due to a fear of falling. Vision scientists warn that this protective strategy puts seniors at risk for social isolation and disability.
› Verified 1 days ago
Dr. Rebecca Trojan, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2830 Crescent Ave, Eugene, OR 97408 Phone: 541-686-9000 Fax: 541-242-4585 | |
John R Lebow, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1755 Coburg Rd Ste 301, Eugene, OR 97401 Phone: 541-344-8225 Fax: 541-744-7322 | |
Stephan M Schepergerdes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4135 Quest Dr, Eugene, OR 97402 Phone: 541-461-8006 Fax: 541-463-2197 | |
Trek Lyons, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Coburg Rd, Eugene, OR 97401 Phone: 541-485-8111 | |
Donna M Byrne, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4135 Quest Dr, Eugene, OR 97402 Phone: 541-461-8006 Fax: 541-463-2197 | |
Dr. Rachel Jean Nosce, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 598 E 13th Ave, Eugene, OR 97401 Phone: 541-640-7625 |